Update
$BioLine Rx(BLRX.US$ Benzinga· 1 min ago
BioLineRx Announces Multi-Center Phase 1 Trial Sponsored By St. Jude Children's Research Hospital To Evaluate Motixafortide For CD34+ Hematopoietic Stem Cell Mobilization For Gene Therapy Applications In Sickle Cell Disease
BioLineRx Announces Multi-Center Phase 1 Trial Sponsored By St. Jude Children's Research Hospital To Evaluate Motixafortide For CD34+ Hematopoietic Stem Cell Mobilization For Gene Therapy Applications In Sickle Cell Disease
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Sean Parker : let's hope it goes up when the market opens. doesn't seem like people are interested yet
.
Trytosaveabit OP Sean Parker : True! Hard to say if they will like it? GL
Sean Parker Trytosaveabit OP : I feel like it's good news all around. plus with a 21PT I'm not sure how .7 doesn't seem like a good buy. I know I sold what I could and bought in.
Trytosaveabit OP Sean Parker : Right! Can’t say that I disagree with your assessment! Hehehe